KU60019 treatment markedly impaired SKOV3 cell migration, an effect substantially reversed through DGAT1 inhibition, and the effect on tumor cells was greater than that on non-tumor cells (Fig 4a,b). This evidence concerns the gene DGAT1 and neoplasm.